Brief: Rain Oncology Q3 Net Income USD -7.034 Million
09/11/2023 21:01
Nov 09 (Reuters) - Rain Oncology Q3 basic EPS USD -0.19. * Q3 income from operations USD -8.078 million * Q3 operating expenses USD 8.078 million
Recent news on Rain Oncology
See all newsBrief: Rain Enhancement Technologies Holdco - May Offer Up To $25 Million In Securities From Time To Time - SEC Filing
Brief: Rain Enhancement Technologies Holdco Inc - Q1 And Q2 2025 Financial Statements Should Not Be Relied Upon Due To Accounting Error - SEC Filing
Brief: Rain Oncology Pursuant To Proposed Deal With Pathos AI
Brief: Rain Oncology To Be Acquired By Pathos AI For $1.16 In Cash Per Share Plus Contingent Value Rights
Brief: Rain Oncology Q3 Net Income USD -7.034 Million